rheumatologylinx Medical News

Email
Password
Remember me
Forgot your Password?
Invite Code?

Home
General Rheumatology

For Practicing
Rheumatologists

Conferences

Jobs

Newsletters

My Library

Topics in
Rheumatology

Amyloidosis

Autoimmune/Heritable

Basic Science/Genetics

Bone Metabolism

Chr Fatigue/Fibromyalgia

Clinical Pharmacology

Connective Tissue Dz

Diagnostics/Radiology

Economics of Medicine

Gout and Hyperuricemia

Infectious Arthritis

Osteoarthritis

Other Arthritis

Pediatric Rheumatology

Popular Press

Rheumatoid Arthritis

Spondylarthropathies

Systemic Lupus (SLE)

Vasculitic Syndromes

Help

Resource Center

RSS News Feeds

Send Newsletter
to a Friend

Sponsor

For Practicing Rheumatologists

Today's Rheumatology News: New Treatment Recommendations For RA
D Scott Cunningham MD, PhD, MDLinx Rheumatology

From the Editors: New Clinical-Only Option for MDLinx!
Stephen Smith, MDLinx

See all

rheumatology, rheumatologist, arthritis journals, medical news, journal, article, lupus, SLE, gout, amyloidosis, infectious arthritis, juvenile rheumatoid arthritis, JRA, rheumatoid arthritis, RA, osteoarthritis, arthritis, spondylarthropathies, bone metabolism, connective tissue disorder, chronic fatigue, fibromyalgia, vasculitis, rheumatism, CDJ, BSE. mad cow, Musculoskeletal

Article Summary

Click the title below to leave the MDLinx Network and go to the Journal's Website

Association of interferon regulatory factor 5 haplotypes, similar to that found in systemic lupus erythematosus, in a large subgroup of patients with rheumatoid arthritis
Arthritis & Rheumatism, 05/14/08

Email This Article

Save in My Library

Free Abstract

Dieguez-Gonzalez R et al. - IRF5 polymorphisms seem to influence RA susceptibility in a large subgroup of patients, following a pattern of association very similar to that described in patients with systemic lupus erythematosus.

Sponsor

--- RHEUMATOID ARTHRITIS TOP ARTICLES ---

Receive free subspecialty "5-minute updates" via email

Tuberculosis reactivation during immunosuppressive therapy in rheumatic diseases: Diagnostic and therapeutic strategies.
Current Opinion in Rheumatology, 06/10/08

Efficacy and safety of etanercept 50 mg twice a week in patients with rheumatoid arthritis who had a suboptimal response to etanercept 50 mg once a week: Results of a multicenter, randomized, double-blind, active drug-controlled study
Arthritis & Rheumatism, 06/27/08

Polymyalgia rheumatica and giant-cell arteritis
The Lancet, 07/22/08

...All of Rheumatoid Arthritis

Sponsor

Read a Different Specialty

Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT

Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology

Orthopedics
Pediatrics
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Profession Index

Dentist
Hospital Administrator
Nurse

Medical Students
Nurse Practitioner
Pharma/Drug Marketer

Pharmacist
Physician
Physician Assistants

Article Search

Keyword:

Search:

Published within:

Sort By:
Date Relevance

Sponsor